Biostimulants sales will expand through 2036, with extract-based at 42.0% within the active ingredient segment in 2026. The market was valued at USD 4.10 billion in 2025, is projected to reach USD 12.30 billion by 2036 and is forecast to record a 10.5% CAGR between 2026 and 2036.